56830-76-3

Basic information

• Product Name: N-(Mesitylsulfonyl)carbamic acid tert-butyl ester
• Synonyms: N-(Mesitylsulfonyl)carbamic acid tert-butyl ester
• CAS NO: 56830-76-3
• Molecular Formula: C₁₄H₂₁NO₄S
• Molecular Weight: 299.39
• Mol File: 56830-76-3.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(Mesitylsulfonyl)carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-(Mesitylsulfonyl)carbamic acid tert-butyl ester(56830-76-3)
• EPA Substance Registry System: N-(Mesitylsulfonyl)carbamic acid tert-butyl ester(56830-76-3)

Safety Data

• Hazardous Substances Data: 56830-76-3(Hazardous Substances Data)

Upstream product

• 773-64-8 2-mesitylenesulphonyl chloride 
• 36016-38-3 tert-Butyl N-hydroxycarbamate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 4543-58-2 2,4,6-trimethylbenzenesulfonamide 

Downstream Products

• 161452-09-1 N-(tert-butoxycarbonyl)-N-(4-aminobutyl)mesitylenesulfonamide 
• 161452-10-4 N-(tert-butoxycarbonyl)-N, N'-bis(mesitylenesulfonyl)-1,4-diaminobutane 
• 161452-20-6 1,6,11-tris(mesitylenesulfonyl)-1,6,11-triazatridecane 
• 161452-19-3 1-(tert-butoxycarbonyl)-1,6,11-tris(mesitylenesulfonyl)-1,6,11-triazatridecane 
• 161452-21-7 3,7,12,17-tetrakis(mesitylenesulfonyl)-3,7,12,17-tetraazanonadecane 
• 161452-22-8 N¹,N⁵,N¹⁰,N¹⁴-tetrakis(mesitylenesulfonyl)-N¹-(tert-butyl)-N¹⁴-ethylhomospermine 
• 1202704-61-7 1,2-diamino-4-bromopyridin-1-ium-2,4,6-trimethylbenzenesulfonate 
• 1361181-57-8 C₁₃H₁₇NO₂S 
• 1361181-64-7 C₂₂H₂₅NO₂S 
• 189341-53-5 3,8,14-Tris(mesitylenesulfonyl)-3,8,14-Triazahexadecane 
• 189341-51-3 N¹,N⁴-bis(mesitylenesulfonyl)-N⁴-ethyl-1,4-diaminobutane 
• 189341-49-9 N¹,N⁴-bis(mesitylenesulfonyl)-N¹-(tert-butoxycarbonyl)-N⁴-ethyl-1,4-diaminobutane 
• 161452-08-0 N-(tert-butoxycarbonyl)-N-(3-cyanopropyl)mesitylenesulfonamide 

Relevant articles and documents

Substituted heteroaryl compounds and compositions and uses thereof (by machine translation)

The invention discloses substituted heteroaryl compounds and compositions thereof and their use. The compounds of formula (I) compound or type shown in (I) a compound represented by stereo isomers, tautomers, nitrogen oxide, solvate, metabolite, pharmaceutically acceptable salt or its prodrug. The invention also provides a pharmaceutical composition, the compounds and pharmaceutical compositions can be regulated protein kinase, particularly Aurora kinase and JAK kinase activity, for the prevention, treatment, treatment and reduce protein kinase, in particular JAK kinase activity mediated diseases or disorders. (by machine translation)

Antiproliferative Properties of Polyamine Analogues: A Structure-Activity Study

A basis set of polyamine analogues was designed and synthesized.These compounds were used to initiate a systematic investigation of the role of chain length, terminal nitrogen alkyl group size, and symmetry of the methylene backbone in the antineoplastic